Dyne Therapeutics reported one-year Phase 1/2 ACHIEVE trial data showing sustained improvements in measures of myotonia, muscle strength, mobility and patient-reported health among people with myotonic dystrophy type 1 taking investigational z-basivarsen. The company said the treatment had a favorable safety profile; registrational expansion results are expected in 2027 and could support a U.S. accelerated approval application.

Health· Sep 29, 2026

Facts from Wikidata (CC0). Image by Steve Jurvetson from Los Altos, USA via Wikimedia Commons (CC BY 2.0).

magnetic confinement fusion

approach to generating fusion power that uses magnetic fields to confine fuel

0members1here now

Ask Genius Site

Site Journal

Feed Discussions About

Sort by

Content type

Latest magnetic confinement fusion news and discussion

Sort by

Content type

magnetic confinement fusion· Health · 8 sources · Sep 29, 2026Story

Dyne Reports One-Year DM1 Trial Improvements

Health· Sep 29, 2026

Facts from Wikidata (CC0). Image by Steve Jurvetson from Los Altos, USA via Wikimedia Commons (CC BY 2.0).

magnetic confinement fusion across IJR

Ask Genius by OpenServe about magnetic confinement fusion Create in Studio Build a game Watch videos

About magnetic confinement fusion

Magnetic confinement fusion (MCF) is an approach to generate thermonuclear fusion power that uses magnetic fields to confine fusion fuel in the form of a plasma. Magnetic confinement is one of two major branches of controlled fusion research, along with inertial confinement fusion.

members

here now

Coverage spread L40 / C60 / R0

Everything about magnetic confinement fusion →

Live room · 1 here

Be the first in the room — members see you arrive.

Join the room

magnetic confinement fusion across IJR

Ask Genius by OpenServe about magnetic confinement fusion Create in Studio Build a game Watch videos